Axovant Sciences Ltd. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (13)

Latest Posts

About This Stock More About This Stock
Above The 40 – A Market Soaring Back To The Edge Of Overbought
Article By: Dr. Duru
Friday, January 12, 2018 5:27 AM EDT
The S&P 500 made another all-time high yesterday, but AT40 rallied just short of the overbought threshold by closing at 69.0%, and the VIX closed with a gain 5 out of the last 6 trading days.
In this article: CAT, DPZ, KBH, FSLR, QQQ, ULTA, SPY, XRT, COMP, VIX, AXON
Read
Axovant Surges After Appointing New CEO Who Led Medivation To $14B Buyout
Article By: The Fly
Monday, April 10, 2017 3:42 PM EDT
Shares of Axovant Sciences are surging after Dr. David Hung was named Chief Executive Officer.
In this article: AXON Also: PFE
Read
Embrace Low-Cap Biotech For High Gains: Eden Rahim Of Next Edge Capital
Article By: The Life Sciences Report
Thursday, March 3, 2016 7:53 AM EDT
Eden Rahim of Toronto-based Next Edge Capital describes a group of micro-, small- and mid-cap biotech names possessing powerful growth drivers that could perform even when the overall market is not so hot.
In this article: LLY, MBXBF, IBB, BIIB, REPCF, XLV, BCLI, AXON, CPHR, NTRP, SGYP, ACAD, MDVN, PTLA, ITCI, ALPMF
Read
Axovant Sciences Ltd (AXON) Soars 95 Percent On IPO
Article By: ValueWalk
Thursday, June 11, 2015 2:21 PM EDT
The shares of Axovant Sciences skyrocketed during its initial public offering (IPO) on the New York Stock Exchange (NYSE) today.
In this article: AXON
Read

PARTNER HEADLINES

Latest Tweets for $AXON

No tweets yet!